Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms, Germ Cell and Embryonal × tremelimumab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 7 Prostatic Neoplasms 6 Diabetes Mellitus, Insulin-Dependent, 12 6 Melanoma 5 Carcinoma, Non-Small-Cell Lung 5 Carcinoma, Hepatocellular 5 Breast Neoplasms 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Recurrence 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Urinary Bladder Neoplasms 2 Recurrent Squamous Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Mesothelioma 2 Lung Neoplasms 2 Liver Neoplasms 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Vascular Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Testicular Neoplasms 1 Solid Tumor 1 Sarcoma, Synovial 1

Interventions

pralsetinib 2 pembrolizumab 2 Brentuximab Vedotin 2 Bevacizumab 2 ribociclib 1 fosaprepitant 1 Sunitinib 1 Sirolimus 1 Radiotherapy, Image-Guided 1 Plicamycin 1 Pemetrexed 1 Paclitaxel 1 Oxaliplatin 1 Genistein 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Dexamethasone 1 Cisplatin 1 Carboplatin 1 Aprepitant 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡